| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.6B | $0.9B | $0.7B | $0.5B | $-0.1B | $0.2B | $0.2B |
| Cost of Revenue | $1.0B | $1.3B | $1.4B | $0.9B | $0.7B | $0.4B | $0.2B | $0.2B |
| Gross Profit | $-0.2B | $-0.6B | $-0.5B | $-0.2B | $-0.2B | $-0.4B | $0.0B | $0.0B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.4B | $0.4B | $0.4B | $0.4B | $0.2B | $0.1B | $0.0B | $0.0B |
| Operating Income | $-1.5B | $-2.0B | $-1.3B | $-0.7B | $-0.4B | $-0.5B | $-0.0B | $-0.0B |
| Net Income | $-1.6B | $-2.1B | $-1.4B | $-0.7B | $-0.5B | $-0.6B | $-0.1B | $-0.1B |
| EPS (Basic) | $-1.42 | $-2.68 | $-2.30 | $-1.25 | $-0.82 | — | — | — |
| EPS (Diluted) | $-1.42 | $-2.68 | $-2.30 | $-1.25 | $-0.82 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B | $3.6B | $4.9B | $5.8B | $6.0B | $2.3B | $0.8B | $0.4B |
| Current Assets | $1.4B | $1.5B | $1.8B | $3.3B | $4.4B | $1.6B | $0.3B | $0.2B |
| Cash & Equivalents | $0.4B | $0.2B | $0.1B | $0.7B | $2.5B | $1.3B | $0.1B | $0.0B |
| Total Liabilities | $1.6B | $1.8B | $2.0B | $1.7B | $1.3B | $0.8B | $0.6B | $0.4B |
| Current Liabilities | $0.6B | $0.7B | $1.0B | $0.6B | $0.4B | $0.2B | $0.2B | $0.1B |
| Stockholders' Equity | $1.0B | $1.7B | $2.9B | $4.1B | $4.6B | $1.5B | $0.1B | $0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.5B | $-0.7B | $-1.1B | $-0.8B | $-0.4B | $-0.2B | $-0.1B | $-0.1B |
| Investing Cash Flow | $-0.1B | $-0.4B | $0.7B | $-0.7B | $-1.7B | $-0.1B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.1B | $0.3B | $0.7B | $0.4B | $0.2B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.6B | $1.0B | $0.0B | $-0.1B | $3.6B | $1.5B | $0.3B | $0.1B |